Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti‑HER2, antibody Trastuzimab, for treatment of breast ...
Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...
Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti-HER2, antibody Trastuzimab, for treatment of breast cance ...
The University of Azad Jammu & Kashmir (UAJK) on Monday formally inaugurated the National Outreach Program for University ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated ...
Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
CEPT University marked a significant academic milestone today as it held its 20th Annual Convocation, conferring degrees on ...
A few months after landing the law job I had worked so hard for, I quit. What followed was a tonne of difficult conversations and a lot of odd jobs ...
Phase I human study and preclinical evaluations of OcuRing™-K showed no treatment-related safety concerns, supporting ...
Indonesia's free nutritious meal project (MBG), has been running for over a year. Several problems continue to haunt the free ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second quarte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback